Haematopoietic stem cells (HSCs) primarily reside in the bone marrow where signals generated by stromal cells regulate their self-renewal, proliferation and trafficking. Endosteal osteoblasts 1,2 and perivascular stromal cells including endothelial cells 3 , CXCL12abundant reticular cells 4,5 , leptin-receptor-positive stromal cells 6 , and nestin-green fluorescent protein (GFP)-positive mesenchymal progenitors 7 have all been implicated in HSC maintenance. However, it is unclear whether specific haematopoietic progenitor cell (HPC) subsets reside in distinct niches defined by the surrounding stromal cells and the regulatory molecules they produce. CXCL12 (chemokine (C-X-C motif) ligand 12) regulates both HSCs and lymphoid progenitors and is expressed by all of these stromal cell populations 7-11 . Here we selectively deleted Cxcl12 from candidate niche stromal cell populations and characterized the effect on HPCs. Deletion of Cxcl12 from mineralizing osteoblasts has no effect on HSCs or lymphoid progenitors. Deletion of Cxcl12 from osterixexpressing stromal cells, which include CXCL12-abundant reticular cells and osteoblasts, results in constitutive HPC mobilization and a loss of B-lymphoid progenitors, but HSC function is normal. Cxcl12 deletion from endothelial cells results in a modest loss of long-term repopulating activity. Strikingly, deletion of Cxcl12 from nestin-negative mesenchymal progenitors using Prx1-cre (Prx1 also known as Prrx1) is associated with a marked loss of HSCs, longterm repopulating activity, HSC quiescence and common lymphoid progenitors. These data suggest that osterix-expressing stromal cells comprise a distinct niche that supports B-lymphoid progenitors and retains HPCs in the bone marrow, and that expression of CXCL12 from stromal cells in the perivascular region, including endothelial cells and mesenchymal progenitors, supports HSCs.
Haematopoietic stem cells (HSCs) primarily reside in the bone marrow where signals generated by stromal cells regulate their self-renewal, proliferation and trafficking. Endosteal osteoblasts 1, 2 and perivascular stromal cells including endothelial cells 3 , CXCL12abundant reticular cells 4, 5 , leptin-receptor-positive stromal cells 6 , and nestin-green fluorescent protein (GFP)-positive mesenchymal progenitors 7 have all been implicated in HSC maintenance. However, it is unclear whether specific haematopoietic progenitor cell (HPC) subsets reside in distinct niches defined by the surrounding stromal cells and the regulatory molecules they produce. CXCL12 (chemokine (C-X-C motif) ligand 12) regulates both HSCs and lymphoid progenitors and is expressed by all of these stromal cell populations [7] [8] [9] [10] [11] . Here we selectively deleted Cxcl12 from candidate niche stromal cell populations and characterized the effect on HPCs. Deletion of Cxcl12 from mineralizing osteoblasts has no effect on HSCs or lymphoid progenitors. Deletion of Cxcl12 from osterixexpressing stromal cells, which include CXCL12-abundant reticular cells and osteoblasts, results in constitutive HPC mobilization and a loss of B-lymphoid progenitors, but HSC function is normal. Cxcl12 deletion from endothelial cells results in a modest loss of long-term repopulating activity. Strikingly, deletion of Cxcl12 from nestin-negative mesenchymal progenitors using Prx1-cre (Prx1 also known as Prrx1) is associated with a marked loss of HSCs, longterm repopulating activity, HSC quiescence and common lymphoid progenitors. These data suggest that osterix-expressing stromal cells comprise a distinct niche that supports B-lymphoid progenitors and retains HPCs in the bone marrow, and that expression of CXCL12 from stromal cells in the perivascular region, including endothelial cells and mesenchymal progenitors, supports HSCs.
CXCL12 has a crucial role in maintaining HSC function, including retention in the bone marrow 8, [12] [13] [14] , quiescence 15, 16 and repopulating activity 16 . To test the hypothesis that CXCL12 production by different stromal cell populations has distinct effects on HSCs and lineagecommitted HPCs, we generated a floxed allele of Cxcl12 (Cxcl12 fl ) to delete Cxcl12 conditionally from candidate niche cells in the bone marrow ( Supplementary Fig. 2 ). Deletion of Cxcl12 from endothelial cells and mature osteoblasts was mediated by the Tie2-cre recombinase and osteocalcin (Oc)-cre transgenes, respectively (Oc also known as Bglap). To target Cxcl12 deletion from osteoprogenitors, we used the osterix (Osx)-cre transgene (Osx also known as Sp7), which mediates efficient recombination in mature osteoblasts and osteoblast progenitors 17 . It also targets CXCL12-abundant reticular (CAR) cells, a perivascular stromal cell population implicated in HSC and B-lymphoid progenitor (BLP) maintenance 5, 11 . Finally, we used the Prx1-cre transgene to target multipotent mesenchymal progenitors in the appendicular skeleton. PRX1 is a transcription factor expressed early during limb bud mesoderm development, and Prx1-cre targets all cells derived from limb bud mesoderm 18 . Lineage mapping studies were performed using a Cxcl12 gfp knock-in mouse to define CAR cells 11 . These studies showed that both the Osx-cre and Prx1-cre transgenes efficiently targeted recombination in mature osteoblasts, osteocytes and CAR cells in long bones ( Fig. 1a-d and Supplementary Fig. 3 ).
We generated triple-transgenic mice containing one floxed Cxcl12 allele, one null allele (Cxcl12 fl/2 ) and a cre-recombinase transgene. Total CXCL12 messenger RNA (mRNA) expression in the femoral bone marrow of Oc-cre-and Tie2-cre-targeted mice was similar to that observed in control mice ( Fig. 1e ). In contrast, CXCL12 mRNA expression was reduced by 70% in Osx-cre-targeted mice and was nearly undetectable in Prx1-cre-targeted mice. A similar decrease in CXCL12 protein levels was observed ( Fig. 1f ). To confirm Cxcl12 deletion from CAR cells, mice containing Cxcl12 fl/gfp and either the Osx-cre or the Prx1-cre transgene were generated (the Cxcl12 gfp allele is a null allele). Indeed, CXCL12 mRNA, although still detectable, was markedly reduced in CAR cells that were sorted from these mice ( Fig. 1g ). As expected, CXCL12 mRNA was nearly undetectable in endothelial cells sorted from Tie2-cre-targeted mice ( Fig. 1h ). Together these data suggest that, under basal conditions, the majority of CXCL12 is produced by CAR cells, with mature osteoblasts and endothelial cells being only minor contributors.
All conditional knockout mice had normal peripheral blood counts and the same relative percentage of granulocytes, monocytes, B cells and T cells ( Supplementary Table 1 ). However, bone marrow cellularity in femurs was reduced by approximately 50% in both the Osxcre-and Prx1-cre-targeted mice, which was due, in part, to a loss of B cells. HPC subsets in the bone marrow were quantified by flow cytometry (Fig. 2a ). The number of c-KIT 1 SCA1 1 LIN 2 (KSL) cells, short-term HSCs, multipotent progenitors and myeloid-committed progenitors was similar in all mice with the exception of a twofold decrease in common myeloid progenitors in Prx1-cre-targeted mice ( Supplementary Fig. 4 ). Loss of CXCL12 expression in endothelial cells or mature osteoblasts had no effect on the number of phenotypic HSCs ( Fig. 2b-d ). The frequency of phenotypic HSCs in the bone marrow of Osx-cre-targeted mice was comparable to control mice (data not shown); however, because bone marrow cellularity was reduced, a modest decrease in the absolute number of HSCs was observed. In contrast, a significant decrease in both the frequency and absolute number of phenotypic HSCs in Prx1-cre-targeted mice was observed, with nearly undetectable dormant HSCs (FLK2 2 CD34 2 CD150 1 CD48 2 KSL cells). Consistent with these findings, competitive repopulation assays showed a significant multilineage long-term repopulating defect using bone marrow from Prx1-cre-but not Osx-cre-targeted mice ( Fig. 3a, b ). Despite the normal number of phenotypic HSCs, a small but significant decrease in long-term repopulating activity also was observed using Tie2-cre-targeted bone marrow. Serial transplantation of bone marrow from Prx1-cre-or Tie2-cre-targeted mice showed no further decrease in repopulating activity in secondary recipients, suggesting that self-renewal capacity may be restored when HSCs are exposed to a normal stromal microenvironment (Supplementary Fig. 5 ). Quiescence is a fundamental property of HSCs and is closely related to long-term repopulating activity 19 . Increased cycling of HSCs was observed in Prx1-cre-but not Osx-cre-or Tie2cre-targeted cells. In contrast, increased cycling of more mature KSL progenitors was observed in both Prx1-cre-and Osx-cre-targeted cells ( Fig. 3c, d ). Collectively, these data show that CXCL12 production by Prx1-cre-targeted stromal cells and, to a lesser extent, endothelial cells is required for maintenance of HSC repopulating activity and quiescence. Consistent with results from a companion paper 20 , our data suggest that CXCL12 production by mature osteoblasts and osteoblast precursors is dispensable for HSC maintenance.
Because CXCL12 has been shown to be important in the retention of HPCs within the bone marrow 5,21 , we next quantified HPCs in the blood and spleen. In Osx-cre-targeted mice, the number of colonyforming cells and KSL cells was increased in the blood and spleen, demonstrating constitutive HPC mobilization (Fig. 3e , f and Supplementary Fig. 6 ). Notably, although CXCL12 expression in the bone marrow is significantly lower in Prx1-cre-targeted mice relative to Osx-cre-targeted mice, both mouse lines showed a similar magnitude of HPC mobilization. Thus, our data suggest that, although CXCL12 production from Osx-cre-targeted stromal cells is largely dispensable for HSC maintenance, it is required for the efficient retention of HPCs in the bone marrow. 5) . e, CXCL12 mRNA expression relative to b-actin mRNA, shown on total bone marrow RNA (n 5 6-13). f, CXCL12 protein in bone marrow extracellular fluid as measured by enzyme-linked immunosorbent assay (n 5 3-5). g, CAR cells were sorted from Osx-cre Cxcl12 gfp/fl (Osx-GFP) or Prx1-cre Cxcl12 gfp/fl (Prx1-GFP) mice, and RNA was prepared. Shown is CXCL12 mRNA expression relative to b-actin mRNA (n 5 5-7). h, CD31 1 LIN 2 CD45 2 endothelial cells were sorted from Tie2-cretargeted and control mice, and RNA was prepared. Shown is CXCL12 mRNA expression relative to b-actin mRNA (n 5 3). *P , 0.05, **P , 0.01, ***P , 0.001. NS, not significant.
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CXCL12 is required for normal B-and T-cell development 12, 22 . Prepro B cells are found in close association with CAR cells 11 , and ablation of CAR cells is associated with a loss of common lymphoid progenitors (CLPs) and pro B cells 4 . Here we show that deletion of Cxcl12 from mineralizing osteoblasts or endothelial cells has no effect on CLPs, BLPs or pre-pro B cells ( Fig. 2e-h and Supplementary Fig. 7 ). In contrast, Cxcl12 deletion from CAR cells using Osx-cre results in a marked loss of pre-pro B cells and a trend towards a loss of BLPs. However, the number of CLPs and earliest thymic progenitors in the thymus are normal. Deletion of Cxcl12 by Prx1-cre-targeted stromal cells results in a similar phenotype but also results in a marked loss of CLPs. Deletion of Cxcl12 in osteoblasts using Col2.3-cre also results in a modest decrease in CLPs and lymphoid-primed multipotent progenitors 20 . Together, these data suggest that CXCL12 production by CAR cells or osteoblast precursors, but not mineralizing osteoblasts or endothelial cells, is required for the maintenance of B-lymphoid-committed progenitors, and that CLP maintenance is supported by CXCL12 production from both endosteal osteoblasts and a Prx1-cre-targeted perivascular stromal cell population. The normal CLPs in Osx-cre-targeted mice may be secondary to compensatory changes related to the severe loss of pre-pro B cells.
We next performed studies to define the stromal cell populations differentially targeted by Prx1-cre and Osx-cre. We first considered the possibility that Prx1-cre may target endothelial cells in the bone marrow. However, we detected no tdTomato expression in bone marrow endothelial cells from Prx1-cre reporter mice (Fig. 4a, b) . Moreover, expression of CXCL12 mRNA from sorted CD31 1 endothelial cells from Prx1-cre-targeted mice was comparable to that in control mice ( Supplementary Fig. 8 ). Thus, loss of CXCL12 from bone marrow endothelial cells does not account for the loss of HSCs in Prx1-cre-targeted mice.
We extended the lineage mapping studies to the CD45 2 lineage -PDGFRa 1 SCA1 1 (PaS) cell population, which is enriched for mesenchymal stem cells 23 . Whereas Osx-cre did not target this cell population, approximately 50% of cells were targeted by Prx1-cre, including a subpopulation that expressed intermediate levels of CXCL12 ( Fig. 4c-e ). To evaluate the mesenchymal progenitor activity of the Prx1-cretargeted cells, we sorted Prx1-cre-targeted (tdTomato 1 ) and non-targeted 
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PaS cells and assessed their clonogenic capacity. All of the colonyforming unit fibroblast (CFU-F) activity was contained within the Prx1-targeted PaS cell population, with more than 10% of these cells having CFU-F activity (Fig. 4f, g) . This compares with a CFU-F frequency of approximately 4% in unselected PaS cells 23 and less than 1% in nestin-GFP 1 stromal cells 7 . The Prx1-targeted PaS cells have osteogenic and adipogenic differentiation potential in vitro, consistent with a mesenchymal stem cell phenotype (Fig. 4h, i) . RNA expression profiling of Prx1-targeted PaS cells is notable for the lack of nestin 7 , CD146 (ref. 9) and leptin receptor 6 , all of which have been used to mark stromal cells contributing to HSC maintenance (Supplementary Table 2 ). Notably, other than moderate CXCL12 expression, these cells do not express genes classically associated with HSC maintenance, including kit ligand 6 and angiopoietin-1 (ref. 19) , although high expression of several matrix proteins implicated in HPC regulation (for example proteoglycan 4 (ref. 24 ) and osteonectin 25 ) is present. Collectively, these data suggest that distinct stromal cell niches in the bone marrow exist that regulate specific HPC populations (Supplementary Fig. 1 ). Osterix-expressing stromal cells comprise a niche that supports B-lymphoid progenitors and retains HPCs in the bone marrow, whereas CXCL12 production from nestin 2 leptin receptor 2 mesenchymal progenitors is required for HSC and CLP maintenance. However, our results do not rule out the possibility that CXCL12 expression from a small subset of CAR cells also contributes to HSC and CLP maintenance.
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Targeting of the 
